ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2017

DNA Methylation Governs the Ability of Apoptotic Cells to Suppress Inflammatory Arthritis Via Reciprocal Regulation of IL-6 and TGF-Beta

Clare Notley1, Christine Jordan2, Jenny McGovern2, Mark Brown2 and Michael R. Ehrenstein3, 1Rheumatology, UCL, London, United Kingdom, 2UCL, London, United Kingdom, 3Medicine, University College London, London, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: apoptosis and inflammatory arthritis, DNA Methylation, IL-6

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Apoptotic cells (AC) have potent anti-inflammatory effects. Injection of apoptotic dendritic cells into mice suppresses the severity of antigen-induced arthritis through increased TGFβ production by resident dendritic cells. However, we have shown that AC that have been previously activated with LPS stimulate a spike in IL-6 production in vivo which inhibits TGFβ and abolishes their immunoregulatory capacity. We set out to define the intrinsic properties of AC that govern their immunomodulatory properties.

Methods: Antigen induced arthritis was used to test the effects of AC in vivo. Peripheral blood samples were obtained from patients with rheumatoid arthritis (all fulfilling ACR criteria) and healthy controls. DNA methylation from human and murine AC was assayed by ELISA and HPLC. We modulated the methylation of AC DNA to determine its role in governing the balance between pro- and anti-inflammatory cytokine production. For some experiments DNA isolated from AC were loaded into liposomes to analyse their properties in vivo. All results refer to murine studies except where specified. 

Results: DNA from activated AC was significantly demethylated compared to resting AC. Demethylation of DNA using 5-azacytidine prior to apoptosis induction abrogated the protective effect of resting AC upon inflammatory arthritis. DNA from resting and activated AC loaded into liposomes had identical effects in vivo as the AC cells themselves. Remethylation of the DNA isolated from activated AC using CpG methylase and loaded into liposomes restored their ability to suppress inflammatory arthritis. Suppression of disease was associated with the production of TGFβ, and reversal of suppression with significantly increased IL-6. Apoptotic CD4+ T cells from patients with rheumatoid arthritis were significantly demethylated compared to healthy controls and led to significantly increased production of IL-6 when cultured with healthy macrophages compared to healthy AC which induced increased TGFβ production.  

Conclusion: Our results reveal that DNA methylation acts as the molecular switch that controls the TGFβ dependent regulatory properties of AC. Activated apoptotic cells by virtue of their hypomethylated DNA induce the production of IL-6, which suppresses TGFβ and promotes a pro-inflammatory milieu. Manipulation of activated AC DNA can restore their protective properties offering novel therapeutic approaches for inflammatory arthritis and other autoimmune rheumatic diseases.


Disclosure: C. Notley, None; C. Jordan, None; J. McGovern, None; M. Brown, None; M. R. Ehrenstein, None.

To cite this abstract in AMA style:

Notley C, Jordan C, McGovern J, Brown M, Ehrenstein MR. DNA Methylation Governs the Ability of Apoptotic Cells to Suppress Inflammatory Arthritis Via Reciprocal Regulation of IL-6 and TGF-Beta [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dna-methylation-governs-the-ability-of-apoptotic-cells-to-suppress-inflammatory-arthritis-via-reciprocal-regulation-of-il-6-and-tgf-beta/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-methylation-governs-the-ability-of-apoptotic-cells-to-suppress-inflammatory-arthritis-via-reciprocal-regulation-of-il-6-and-tgf-beta/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology